Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection
Year: 2008
Type: article
Study design: Observational Study
Source: The Oncologist
Institutions: Fudan University, Zhongshan Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: 高转移潜能肝癌细胞抵抗自体吞噬及其分子机制, G7153934551
OpenAlex ID: W2123303768
